Fuad El-Hibri, Director, 10% Owner at Aptevo Therapeutics Inc. (APVO), bought 10,000 shares at $0.90 ($9K) on 2019-07-23, disclosed to the SEC on 2019-07-24.
Open-market purchase of $9k APVO by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Something here stands out, but not much.
| Filing → |
| EBS | SELL | 2020-09-25 | $3.8M | — | Filing → |
| EBS | SELL | 2020-09-18 | $6.1M | — | Filing → |
| EBS | SELL | 2020-09-11 | $4.1M | — | Filing → |